The peptide comprising the cytoplasmic C-terminal tail of CD151 significantly reduced HCMV infection rates in EA.hy926 and HEC-LTT cells, while the peptide of the cytoplasmic C-terminal tail of CD63 significantly decreased HCMV infection rates in all cell lines tested (Figure 5). This evidence concerns the gene CD63 and cytomegalovirus infection.